3481 - 3490 of 6255 Results
Title
Year
-
OPENTitle: Visualizing chaperone-mediated multistep assembly of the human 20S proteasomeJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 8Start Page: 1176End Page: 1188Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41594-024-01268-9Best OA location URL: https://www.nature.com/articles/s41594-024-01268-9.pdfCitation Count: 11
- Self-supervised learning for human activity recognition using 700,000 person-days of wearable data2024OPENTitle: Self-supervised learning for human activity recognition using 700,000 person-days of wearable dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01062-3Best OA location URL: https://www.nature.com/articles/s41746-024-01062-3.pdfCitation Count: 45
-
OPENTitle: Real-World Experiences of Parkinson's Disease OFF Time and Role of DemographicsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 11Issue #: 1Start Page: 8End Page: 17Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.17294/2330-0698.2057Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=2057&context=jpcrrCitation Count: 2
- Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer’s Disease2023OPENTitle: Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 95Issue #: 4Start Page: 1623End Page: 1634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-230543Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10911245Citation Count: 6
-
OPENTitle: Childhood Trauma and Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 13Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200124Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9987208Citation Count: 6
-
OPENTitle: Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 43Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adh3457Best OA location URL: https://doi.org/10.1126/sciadv.adh3457Citation Count: 10
- Image-encoded biological and non-biological variables may be used as shortcuts in deep learning models trained on multisite neuroimaging data2023OPENTitle: Image-encoded biological and non-biological variables may be used as shortcuts in deep learning models trained on multisite neuroimaging dataJournal Name: Journal of the American Medical Informatics AssociationPublisher: Oxford University Press (OUP)Vol: 30Issue #: 12Start Page: 1925End Page: 1933Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/jamia/ocad171Best OA location URL: https://academic.oup.com/jamia/advance-article-pdf/doi/10.1093/jamia/ocad171/51360446/ocad171.pdfCitation Count: 12
- Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson's2023OPENTitle: Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson'sJournal Name: European Journal of NeurosciencePublisher: WileyVol: 59Issue #: 6Start Page: 1242End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1111/ejn.16180Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16180Citation Count: 5
-
OPENTitle: Large-scale rare variant burden testing in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 11Start Page: 4622End Page: 4632Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awad214Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad214/50682984/awad214.pdfCitation Count: 35
-
OPENTitle: How should we be using biomarkers in trials of disease modification in Parkinson’s disease?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 4845End Page: 4869Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad265Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad265/51034903/awad265.pdfCitation Count: 24